Technical Analysis for APS - Aptose Biosciences Inc.

Grade Last Price % Change Price Change
F 1.830 4.57% 0.080
APS closed down 2.78 percent on Tuesday, April 16, 2024, on 73 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 6
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 4.57%
Doji - Bullish? Reversal 4.57%
Below Lower BB Weakness 4.57%
Gapped Down Weakness 4.57%
Lower Bollinger Band Touch Weakness 4.57%
Oversold Stochastic Weakness 4.57%
20 DMA Resistance Bearish 1.67%
MACD Bearish Signal Line Cross Bearish 1.67%
Reversal New Lows Setup Bearish Swing Setup 1.67%
Outside Day Range Expansion 1.67%

   Recent Intraday Alerts

Alert Time
Gap Up Closed about 1 hour ago
Reversed from Up about 1 hour ago
10 DMA Resistance about 1 hour ago
Gapped Up (Full) about 2 hours ago
Rose Above Previous Day's High about 2 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aptose Biosciences Inc. Description

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates that exert activity as stand-alone agents and that enhance the activities of other anticancer agents without causing overlapping toxicities. The Company develops therapeutics focused on epigenetic processes and signal transduction abnormalities at the edge of cancer research, coupled with companion diagnostics to identify the optimal patient population for its products. The Company's APTO-253 is a small molecule that can induce expression of the genes that codes for the Kruppel-like factor 4 (KLF4) master transcription factor and the p21 cell cycle inhibitor protein.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pipe Pipeline Clinic Drug Biotechnology Science Cancer Drugs Biology Genes Chemotherapy Transcription

Is APS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.94
52 Week Low 0.51
Average Volume 8,857
200-Day Moving Average 3.806
50-Day Moving Average 2.258
20-Day Moving Average 1.995
10-Day Moving Average 1.900
Average True Range 0.134
RSI (14) 32.43
ADX 14.75
+DI 20.920
-DI 22.388
Chandelier Exit (Long, 3 ATRs) 1.929
Chandelier Exit (Short, 3 ATRs) 2.111
Upper Bollinger Bands 2.228
Lower Bollinger Band 1.761
Percent B (%b) -0.02
BandWidth 23.455
MACD Line -0.117
MACD Signal Line -0.110
MACD Histogram -0.007
Fundamentals Value
Market Cap 155.51 Million
Num Shares 88.9 Million
EPS -0.59
Price-to-Earnings (P/E) Ratio -2.95
Price-to-Sales 0.00
Price-to-Book 4.32
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.915
Resistance 3 (R3) 1.920 1.870 1.888
Resistance 2 (R2) 1.870 1.828 1.868 1.878
Resistance 1 (R1) 1.810 1.802 1.785 1.805 1.869
Pivot Point 1.760 1.760 1.748 1.758 1.760
Support 1 (S1) 1.700 1.718 1.675 1.695 1.631
Support 2 (S2) 1.650 1.692 1.648 1.622
Support 3 (S3) 1.590 1.650 1.613
Support 4 (S4) 1.585